Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 2.35 is 118% above its 3-year average of 1.08, around the middle of its 3-year range (0.27–3.58).
As of the fiscal period ended Wednesday, December 31, 2025. 13.66% above its 12-month average of 2.07.
Reported quarterly quick ratio; no daily interpolation. Q4 FY2025 (2025-12-31): 2.35.
QUICK RATIO (ACID-TEST)
2.35
QUICK RATIO (ACID-TEST) AVG TTM
2.07
QUICK RATIO (ACID-TEST) AVG 3Y
1.08
QUICK RATIO (ACID-TEST) AVG 5Y
N/A
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+13.66%
CURRENT VS 3Y AVG
+117.66%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.79
median of 433 covered companies
CURRENT VS SECTOR MEDIAN
-15.66%
vs the sector median at left
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares
Market Cap
$6.03M
Quick Ratio (Acid-Test)
2.35
TTM Avg
2.07
3Y Avg
1.08
5Y Avg
N/A
Market Cap
$6.09M
Quick Ratio (Acid-Test)
119.39
TTM Avg
100.04
3Y Avg
53.35
5Y Avg
40.07
Market Cap
$6.10M
Quick Ratio (Acid-Test)
17.15
TTM Avg
11.86
3Y Avg
7.50
5Y Avg
9.06
Market Cap
$6.34M
Quick Ratio (Acid-Test)
0.93
TTM Avg
1.44
3Y Avg
2.71
5Y Avg
3.16
Market Cap
$5.63M
Quick Ratio (Acid-Test)
3.88
TTM Avg
2.19
3Y Avg
2.86
5Y Avg
5.66
Market Cap
$6.44M
Quick Ratio (Acid-Test)
N/A
TTM Avg
2.00
3Y Avg
1.31
5Y Avg
1.05
Market Cap
$5.36M
Quick Ratio (Acid-Test)
3.01
TTM Avg
3.95
3Y Avg
2.52
5Y Avg
4.28
Market Cap
$6.72M
Quick Ratio (Acid-Test)
2.61
TTM Avg
3.40
3Y Avg
4.86
5Y Avg
5.09
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) | $6.03M | 2.35 | 2.07 | 1.08 | N/A |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $6.09M | 119.39 | 100.04 | 53.35 | 40.07 |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $6.10M | 17.15 | 11.86 | 7.50 | 9.06 |
| Femasys Inc. (FEMY)vs › | $6.10M | 0.55 | 1.77 | 4.96 | 6.03 |
| Biomerica, Inc. (BMRA)vs › | $6.34M | 0.93 | 1.44 | 2.71 | 3.16 |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.63M | 3.88 | 2.19 | 2.86 | 5.66 |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.44M | N/A | 2.00 | 1.31 | 1.05 |
| Alzamend Neuro Inc (ALZN)vs › | $5.36M | 3.01 | 3.95 | 2.52 | 4.28 |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.72M | 2.61 | 3.40 | 4.86 | 5.09 |
| Aclarion, Inc. (ACON)vs › | $6.74M | 16.20 | 7.76 | 4.60 | 3.08 |
Quick Ratio
2.35
Excludes inventory
Current Ratio
2.35
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2025-12-31 | 2.35 |
| 2025-06-30 | 3.58 |
| 2024-12-31 | 0.27 |
| 2024-06-30 | 0.30 |
| 2023-12-31 | 0.32 |
| 2023-06-30 | 0.33 |
| 2022-12-31 | 0.41 |
